Literature DB >> 8026405

Development of a novel scale to assess life fulfillment as part of the further refinement of a quality-of-life model for epilepsy.

G A Baker1, A Jacoby, D F Smith, M E Dewey, D W Chadwick.   

Abstract

We have been involved in developing a health-related quality-of-life model for use as an outcome measure in epilepsy. As part of the further development of this model, we have developed a measure of life fulfillment. This scale is based on methods previously described by Krupinski in 1980. The value of Krupinski's approach is the opportunity for patients to weight the numerous aspects of their quality of life and assess the discrepancy between their actual and desired circumstances. The life fulfillment scale has been shown to be reliable (alpha = 0.7) and valid. The scale is currently being applied to several clinical studies in epilepsy. We believe that the scale provides a valuable contribution to our health-related quality-of-life model.

Entities:  

Mesh:

Year:  1994        PMID: 8026405     DOI: 10.1111/j.1528-1157.1994.tb02479.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  13 in total

Review 1.  Quality of life and neurological illness: a review of the literature.

Authors:  R Murrell
Journal:  Neuropsychol Rev       Date:  1999-12       Impact factor: 7.444

2.  Quality of life after epilepsy surgery.

Authors:  M W Kellett; D F Smith; G A Baker; D W Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

3.  Children with epilepsy and anxiety: Subcortical and cortical differences.

Authors:  Jana E Jones; Daren C Jackson; Karlee L Chambers; Kevin Dabbs; David A Hsu; Carl E Stafstrom; Michael Seidenberg; Bruce P Hermann
Journal:  Epilepsia       Date:  2015-01-12       Impact factor: 5.864

Review 4.  Assessing quality of life in patients with epilepsy.

Authors:  A Jacoby
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

5.  The contribution of the measurement of seizure severity to quality of life research.

Authors:  D Smith; G A Baker; A Jacoby; D W Chadwick
Journal:  Qual Life Res       Date:  1995-04       Impact factor: 4.147

Review 6.  Quality of life as an outcome measure for epilepsy clinical trials.

Authors:  J A Cramer
Journal:  Pharm World Sci       Date:  1997-10

7.  Adaptation and evaluation of the Liverpool Seizure Severity Scale and Liverpool Quality of Life battery for American epilepsy patients.

Authors:  S Rapp; S Shumaker; T Smith; P Gibson; R Berzon; R Hoffman
Journal:  Qual Life Res       Date:  1998-08       Impact factor: 4.147

8.  Adaptation and evaluation of the Liverpool Seizure Severity Scale and Liverpool Quality of Life battery for American epilepsy patients.

Authors:  S Rapp; S Shumaker; T Smith; P Gibson; R Berzon; R Hoffman
Journal:  Qual Life Res       Date:  1998-05       Impact factor: 4.147

9.  Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables.

Authors:  C A Espie; J Watkins; L Curtice; A Espie; R Duncan; J A Ryan; M J Brodie; K Mantala; M Sterrick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

10.  Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP).

Authors:  E Besi; D R Boniface; R Cregg; J M Zakrzewska
Journal:  J Headache Pain       Date:  2015-09-03       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.